glp 1 classification glp-1 agonists drug class A schematic overview of receptor agonists: classification, GLP-1 receptor agonists Classification of glucagon-like peptide-1 receptor

Patients and healthcare providers can report suspected adverse events related to these medications to the FDA through the MedWatch program (www.fda.gov/medwatch or 1-800-FDA-1088)

2025 Dec;43(16-18):819-832

We advise our patients to speak with their insurance providers to understand their plans coverage specifics and the possible out-of-pocket costs if the medication isnt covered

Serious but rare adverse effects include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal symptoms), and hypoglycemia when combined with insulin or sulfonylureas

This dual action helps normalize blood glucose with lower risk of hypoglycemia compared to some older diabetes medications, though the risk increases when combined with insulin or sulfonylureas